ADCETRIS 50 mg powder for concentrate for solution for infusion clinical trials
6 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase III, Randomized, Open-label, Clinical Trial to Compare Pembrolizumab with Brentuximab Vedotin in Subjects with Relapsed or Refractory Classical Hodgkin Lymphoma
This study is looking at two medicines, pembrolizumab and brentuximab vedotin, for people with Hodgkin lymphoma that has come back or hasn't responded to other treatments. It wants to see which medicine works better at stopping the cancer from growing and helping people live longer.
For: Hodgkin lymphomaSweden · Czechia · Poland - Ongoing, recruitingTherapeutic exploratory (Phase II)
Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects
This study looks at new ways to treat Hodgkin lymphoma, a type of cancer that affects the immune system. Researchers are testing different combinations of medicines to see how well they work and if they are safe. The main goal is to see if these treatments can make the cancer go away completely.
For: Classical Hodgkin LymphomaSpain · Czechia · Italy - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma
This study looks at a new combination of medicines (A+AVD) compared to a standard treatment (ABVD) for advanced Hodgkin Lymphoma. It aims to see if the new combination can better control the cancer and help people live longer.
For: Advanced Classical Hodgkin LymphomaDenmark · Hungary · Italy - AuthorisedTherapeutic exploratory (Phase II)
A Phase II Open Label Study of Brentuximab Vedotin in Combination with CHEP in Patients with Previously Untreated CD30-expressing Peripheral T-cell Lymphomas (PTCL)
This study is looking at a new combination of medicines, including Brentuximab Vedotin (Adcetris), for adults with a type of cancer called CD30-expressing Peripheral T-cell Lymphoma (PTCL) that hasn't been treated before. We want to see how well this new treatment shrinks the cancer.
For: CancerCzechia - Ongoing, recruitingTherapeutic confirmatory (Phase III)
HD21 for advanced stages - Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 4-6 cycles of escalated BEACOPP with 4-6 cycles of BrECADD
This study compares two common treatments for advanced Hodgkin lymphoma (a type of cancer). It looks at how well they work, their side effects, and their impact on quality of life, especially for older patients.
For: Advanced Stage of Hodgkin LymphomaNorway · Austria · Netherlands - AuthorisedTherapeutic confirmatory (Phase III)
BeCALM - Brentuximab vedotin in CutAneous T-cell Lymphomas (CTCL): post-allogeneic hematopoietic stem cell transplant Maintenance
This study looks at whether a drug called Adcetris can help people with a rare skin cancer (cutaneous T-cell lymphoma) stay cancer-free after a stem cell transplant. We want to see if it prevents the cancer from coming back.
For: rare diseaseFrance